BYETTA is a non-insulin type 2 diabetes injection medication for adults. Important Safety Information for BYETTA (exenatide) injection . with prior severe hypersensitivity reactions to exenatide or to any of the product components. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution for injection in pre-filled pen exenatide. Read all of this leaflet carefully.

Author: Akinotilar Kigam
Country: Eritrea
Language: English (Spanish)
Genre: Video
Published (Last): 20 September 2010
Pages: 398
PDF File Size: 7.32 Mb
ePub File Size: 14.6 Mb
ISBN: 932-2-63229-793-8
Downloads: 99270
Price: Free* [*Free Regsitration Required]
Uploader: Moogurg

Should not be used in patients with severe renal impairment or end-stage renal disease. These may be symptoms of pancreatitis. Tell your healthcare provider if you are pregnant rxenatide plan to become pregnant.

The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness. Patients may develop antibodies to exenatide.

Official BYETTA® (exenatide) injection Healthcare Professional Website

If worsening of or failure to achieve adequate glycemic control occurs, exenatise alternative antidiabetic therapy. Tell your healthcare provider if you have or had kidney problems or a kidney transplant. This product information is intended for US Healthcare Professionals only. Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth.

Drug Interactions Oral Medications: Write your html here Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA.

This site is intended for US Consumers. Inflammation of the pancreas pancreatitis may happen, which may be severe and lead to death.

Add BYETTA to insulin glargine as a complementary action to help improve glycemic control

Pen-sharing poses a risk for transmission of blood-borne pathogens, even if the needle is changed. Use with caution in patients with renal transplantation or when initiating or escalating the dose in patients ihsert moderate renal failure.


It is unknown whether patients with a history of pancreatitis are at increased risk for pancreatitis while using BYETTA; consider other antidiabetic therapies for these pzckage. You are encouraged to report negative side effects of prescription drugs to the FDA.

Before taking BYETTA, tell your healthcare provider if you have had pancreatitis, stones in your gallbladder gallstonesa history of alcoholism, or high blood triglyceride levels. Glucagon-like peptide-1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. To report drug exposure during pregnancy call Concurrent use with prandial insulin has not been studied and cannot be recommended. BYETTA should not be used in people with type 1 diabetes or people with diabetic ketoacidosis a condition caused by very high blood sugar.

You may report side effects related to AstraZeneca products by clicking here. Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery.

Use in pediatric patients is not recommended as safety and effectiveness have not been established. Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema. Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic ketoacidosis.

No placebo-treated patients withdrew due to nausea or vomiting. If pancreatitis is suspected, BYETTA should be discontinued promptly and should not be restarted if pancreatitis is confirmed. Postmarketing reports of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin. The site you are about to visit is maintained by a third party who is solely responsible for its contents.


All other trademarks are property of their respective owners. Stop taking BYETTA and call your healthcare provider right away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going from your abdomen through to your back.

Type 2 Diabetes Medication | BYETTA® (exenatide) injection

AstraZeneca provides this link as a service to website visitors. You may give other people a serious infection, or get a serious infection from them. After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the pzckage, with or without vomiting. Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.

Symptoms of a severe allergic reaction include severe rash or itching, swelling of your face, lips, and throat that may cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat.

exenatiee Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed. Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. All other trademarks are property of their respective owners.

Go to Healthcare Professional Site. Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Use of twice-daily exenatide in basal insulin—treated patients with type 2 diabetes: